Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics
Pediatric Blood & Cancer · 2024-09 · 71 (9)
DOI: 10.1002/pbc.31092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 12.06.2024. Verfasst von Angela Steineck und 10 weiteren Autor:innen. Beteiligte Einrichtung: MACC Fund Center for Cancer and Blood Disorders, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: St. Baldrick's Foundation, T32 Training, American Lebanese Syrian Associated Charities.
Abstract (Originalsprache)
Background
Chimeric antigen receptor (CAR) T‐cell therapy provides promising outcomes in relapsed/refractory B acute lymphoblastic leukemia (ALL), yet still carries high toxicity rates and relatively poor long‐term survival. Efficacy has yet to be demonstrated in other diagnoses while toxicity and risk profiles remain formidable. To date, treatment‐related symptom burden is gleaned from clinical trial toxicity reports; the patient perspective remains understudied.
Methods
English‐ or Spanish‐speaking patients (ages 8–25 years) undergoing CAR T‐cell therapy for any malignancy and their primary caregivers were recruited from Seattle Children's Hospital (SCH), St. Jude Children's Research Hospital (SJCRH), and the Pediatric Oncology Branch of the National Cancer Institute (NCI). Both patient and caregiver completed semi‐structured dyadic interviews 3 months post treatment. We used directed content analysis for codebook development and thematic network analysis for inductive qualitative analysis.
Results
Twenty families completed interviews (13 patients, 15 parents). Patients were a median age 16.5 years, predominantly female (65%), White (75%), and diagnosed with ALL (75%). Global themes included “A clear decision,” “Coping with symptoms,” and “Unforeseen psychosocial challenges.” When families were asked to describe the “most challenging part of treatment,” most described “the unknown.” Most reported “the symptoms really weren't that bad,” even among patients hospitalized for severe toxicity events. Fatigue, pain, and nausea were the most prevalent symptoms. Importantly, only one family would have chosen a different therapy, if given another opportunity.
Conclusions
Although physical symptoms were largely tolerable, recognizing supportive care opportunities remains imperative, particularly psychosocial concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MACC Fund Center for Cancer and Blood Disorders, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
- Medical School, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- College of Medicine, Health Sciences Center, University of Tennessee, Memphis, Tennessee, USA.
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Psychosocial Oncology & Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
ORCID-Profile: Angela Steineck, Lori Wiener
Förderung
- St. Baldrick's Foundation
- T32 Training
- American Lebanese Syrian Associated Charities
- Intramural Program of the National Cancer Institute
- NCI NIH HHS
- NIH HHS
- Conquer Cancer Foundation
- NHLBI NIH HHS
Zitieren
APA
Steineck, A., Silbert, S. K., Palm, K., Nepper, J., Vaughn, D., Shipman, K., Shalabi, H., Wiener, L., Comiskey, L., Knight, J. M., & Levine, D. (2024). Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics. Pediatric Blood & Cancer, 71(9). https://doi.org/10.1002/pbc.31092
Vancouver
Steineck A, Silbert SK, Palm K, Nepper J, Vaughn D, Shipman K, et al. Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics. Pediatric Blood & Cancer. 2024;71(9). doi:10.1002/pbc.31092
BibTeX
@article{Steineck2024,
author = {Steineck, Angela and Silbert, Sara K and Palm, Kallie and Nepper, Jordyn and Vaughn, Dagny and Shipman, Kelly and Shalabi, Haneen and Wiener, Lori and Comiskey, Liam and Knight, Jennifer M and Levine, Deena},
title = {Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics},
journal = {Pediatric Blood & Cancer},
year = {2024},
volume = {71},
number = {9},
doi = {10.1002/pbc.31092}
}
EUVIMED